TLCM
VIR icon

Twin Lakes Capital Management’s Vir Biotechnology VIR Stock Holding History

Twin Lakes Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4K Hold
2,195
– – 0.01% 156
2026
Q1 		$19.7K Hold
2,195
– – 0.01% 168
2025
Q4 		$13.2K Hold
2,195
– – 0.01% 183
2025
Q3 		$12.5K Hold
2,195
– – 0.01% 185
2025
Q2 		$11.1K Hold
2,195
– – 0.01% 188
2025
Q1 		$14.2K Hold
2,195
– – 0.01% 176
2024
Q4 		$16.1K Hold
2,195
– – 0.01% 183
2024
Q3 		$16.4K Hold
2,195
– – 0.01% 187
2024
Q2 		$19.5K Hold
2,195
– – 0.01% 176
2024
Q1 		$22.2K Hold
2,195
– – 0.02% 173
2023
Q4 		$22.1K Hold
2,195
– – 0.02% 169
2023
Q3 		$20.6K Hold
2,195
– – 0.02% 174
2023
Q2 		$53.8K Hold
2,195
– – 0.04% 134
2023
Q1 		$51.1K Hold
2,195
– – 0.04% 133
2022
Q4 		$55.6K Hold
2,195
– – 0.04% 131
2022
Q3 		$42K Buy
+2,195
New +$55.8K 0.03% 147
2022
Q2 		– Sell
-2,195
Closed -$56K – 281
2022
Q1 		$56K Hold
2,195
– – 0.03% 151
2021
Q4 		$92K Hold
2,195
– – 0.05% 124
2021
Q3 		$96K Hold
2,195
– – 0.06% 114
2021
Q2 		$104K Buy
+2,195
New +$99.8K 0.06% 98

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Twin Lakes Capital Management's VIR Position: Q2 2026 in Review

Twin Lakes Capital Management held its Vir Biotechnology (VIR) position steady in Q2 2026 at 2,195 shares worth $22.4K. The position accounts for 0.01% of the portfolio, ranked #156.

Twin Lakes Capital Management first reported a position in VIR in Q2 2021 and has held it in 20 quarters since. The position peaked at $104K in Q2 2021. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Twin Lakes Capital Management held 2,195 shares of Vir Biotechnology worth $22.4K as of Q2 2026.
  • Twin Lakes Capital Management left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up 0.01% of Twin Lakes Capital Management's portfolio in Q2 2026, its #156 holding.
  • Twin Lakes Capital Management first reported a position in Vir Biotechnology in Q2 2021 and has held it in 20 quarters since.
  • Twin Lakes Capital Management's Vir Biotechnology position peaked at $104K in Q2 2021.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Twin Lakes Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.